Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms 
US Strikes Iran Again After Strait of Hormuz Tanker Attack Escalates Ceasefire Tensions 
Australia Plans Higher Fines for Social Media Firms Failing to Block Underage Users 
Trump Urges Gasoline Retailers to Cut Prices to $2.50 Per Gallon, Warns of Legal Action 
China Expands Export Controls, Adds 20 Japanese Companies to Restricted List 
US, Iran Agree to Halt Attacks Ahead of Doha Talks on Strait of Hormuz 
Javier Milei Cabinet Chief Manuel Adorni Resigns Amid Spending Scandal Investigation 
Serbia Protests Continue as Thousands Rally Despite Vucic’s Resignation Plan 
Despite its best efforts, Iran won’t be able to toll the Strait of Hormuz. Here’s why 
Australia, Vanuatu Sign Security Pact Amid Pacific Influence Competition 
Supreme Court Backs Lisa Cook, Defends Federal Reserve Independence Against Trump Firing Attempt 
Mexico, U.S. Launch Sterile Fly Facility to Combat New World Screwworm Outbreak 
Iran Launches Drone Attack on Bahrain After U.S. Strikes, Strait of Hormuz Tensions Escalate 
Russia Intensifies Assault on Kostiantynivka as Ukraine’s Donetsk Defense Faces Mounting Pressure 
Sheinbaum Says No One Is Above the Law After Abuse Video of Ex-Pemex Chief Emerges 
Russian Attacks Kill Four in Ukraine as Zaporizhzhia and Kharkiv Come Under Fire 
Taiwan Coast Guard Officer Finds Strength in Faith as China Increases Pressure in Taiwan Strait 
U.S. President Donald Trump recently sparked renewed discussion around cannabidiol regulation after calling on Congress to modernize existing laws to allow broader access to “full-spectrum” CBD products. In a post shared on Truth Social, Trump emphasized the need for updated legislation that ensures Americans can benefit from the full range of hemp-derived compounds, not just isolated CBD.
Full-spectrum CBD refers to products that contain a variety of naturally occurring cannabinoids, terpenes, and other compounds found in the cannabis plant, including trace amounts of THC within federally legal limits. Advocates argue that these compounds work together in what is known as the “entourage effect,” potentially enhancing the therapeutic benefits of CBD for issues such as anxiety, chronic pain, inflammation, and sleep disorders.
Trump’s statement highlights a growing debate in the U.S. CBD market, where current regulations remain fragmented and often unclear. While the 2018 Farm Bill legalized hemp-derived CBD at the federal level, restrictions and inconsistencies continue to limit consumer access to certain formulations, particularly full-spectrum products. Industry leaders and stakeholders have long pushed for clearer guidelines to support innovation, ensure product safety, and expand market opportunities.
The call for reform also reflects increasing consumer demand for natural wellness solutions. The global CBD market has seen rapid growth, driven by rising awareness of its potential health benefits and shifting public perception of cannabis-related products. However, regulatory uncertainty has slowed progress in areas such as product labeling, quality control, and interstate commerce.
By urging Congress to revisit CBD legislation, Trump has added momentum to ongoing discussions about cannabis policy reform in the United States. Supporters believe that updated laws could strengthen the domestic hemp industry, create jobs, and provide consumers with safer, more effective CBD options. As lawmakers consider potential changes, the future of full-spectrum CBD products in the U.S. remains a closely watched issue for both businesses and consumers alike.
